TET2 |
|
|
|
Age(>65y), % |
36.2 |
61.2 |
0.005 |
BM blasts(>10 %), % |
37.8 |
17 |
0.008 |
WBC(109/L), median, range |
12.96(3.05–98.03) |
16.00(3.01–70.50) |
0.961 |
ANC(109/L), median, range |
5.83(0.30–66.91) |
8.78(1.12–28.64) |
0.617 |
AMC(109/L), median, range |
3.06(1.02–18.00) |
3.13(1.06–17.63) |
0.874 |
Hb(g/L), median, range |
91.0(43.0–158.0) |
88.0(43.0–166.0) |
0.409 |
PLT(109/L), median, range |
68.0(3.8–895.0) |
87.0(9.0–1001.0) |
0.866 |
SRSF2 |
|
|
|
Age(>65y), % |
24.2 |
64.1 |
0.000 |
BM blasts(>10 %), % |
33 |
26.2 |
0.361 |
WBC(109/L), median, range |
11.47(3.01–98.03) |
21.35(5.06–70.50) |
0.007 |
ANC(109/L), median, range |
4.92(0.30–66.91) |
13.55(1.75–33.90) |
0.008 |
AMC(109/L), median, range |
2.29(1.02–18.00) |
3.72(1.16–17.63) |
0.004 |
Hb(g/L), median, range |
84.0(43.0–166.0) |
106.5(56.0–166.0) |
0.000 |
PLT(109/L), median, range |
67.5(3.8–895.0) |
100.0(9.0–1001.0) |
0.392 |
ASXL1 |
|
|
|
Age(>65y), % |
52.3 |
53.8 |
0.863 |
BM blasts(>10 %), % |
28.8 |
38.8 |
0.393 |
WBC(109/L), median, range |
11.47(3.01–92.40) |
20.10(3.62–98.03)) |
0.123 |
ANC(109/L), median, range |
5.17(0.30–66.91) |
10.45(0.46–56.66) |
0.052 |
AMC(109/L), median, range |
2.52(1.06–18.00) |
3.20(1.02–14.82) |
0.082 |
Hb(g/L), median, range |
92.0(44.0–166.0) |
87.5(43.0–158.0) |
0.187 |
PLT(109/L), median, range |
69.0(6.6–1001.0) |
90.5(3.8–633.0) |
0.487 |
SETBP1 |
|
|
|
Age(>65y), % |
57.7 |
52.1 |
0.605 |
BM blasts(>10 %), % |
29.4 |
38.5 |
0.415 |
WBC (109/L), median, range |
12.69(3.01–98.03) |
20.46(6.60–49.10) |
0.173 |
ANC (109/L), median, range |
5.50(0.30–66.91) |
11.75(2.56–33.90) |
0.079 |
AMC (109/L), median, range |
2.62(1.06–18.00) |
3.25(1.02–11.03) |
0.413 |
Hb(g/L), median, range |
88.5(43.0–166.0) |
90.5(52.0–137.0) |
0.622 |
PLT(109/L), median, range |
74.25(5.0–1001.0) |
118.5(3.8–534.0) |
0.337 |